Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters.Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology…
Tenaya Therapeutics’ $50 Common Stock Offering
![](https://globallegalchronicle.com/wp-content/uploads/2024/02/tenaya-therapeutics-50-common-stock-offering_65dc542104f5f-480x360.jpeg)